A detailed history of Rhumbline Advisers transactions in Edap Tms Sa stock. As of the latest transaction made, Rhumbline Advisers holds 3,438 shares of EDAP stock, worth $10,795. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,438
Previous 4,478 23.22%
Holding current value
$10,795
Previous $32,000 43.75%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 01, 2024

SELL
$5.17 - $8.5 $5,376 - $8,840
-1,040 Reduced 23.22%
3,438 $18,000
Q1 2024

May 09, 2024

SELL
$5.1 - $7.78 $545 - $832
-107 Reduced 2.33%
4,478 $32,000
Q4 2023

Feb 08, 2024

BUY
$4.15 - $7.2 $664 - $1,152
160 Added 3.62%
4,585 $24,000
Q3 2023

Nov 09, 2023

BUY
$6.2 - $9.34 $3,348 - $5,043
540 Added 13.9%
4,425 $31,000
Q2 2023

Aug 08, 2023

BUY
$8.76 - $11.92 $34,032 - $46,309
3,885 New
3,885 $35,000

Others Institutions Holding EDAP

About EDAP TMS SA


  • Ticker EDAP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 36,145,300
  • Market Cap $113M
  • Description
  • EDAP TMS S.A., together with its subsidiaries, develops, produces, markets, distributes, and maintains a portfolio of minimally invasive medical devices for the treatment of urological diseases in Asia, France, the United States, and internationally. It operates in three segments: High Intensity Focused Ultrasound (HIFU), Extracorporeal ShockWav...
More about EDAP
Track This Portfolio

Track Rhumbline Advisers Portfolio

Follow Rhumbline Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.